A Multiple Dose Opioid Challenge Study

NCT02611752 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate or Severe Opioid Use Disorder

Interventions

DRUG: CAM2038

Sponsor

Braeburn Pharmaceuticals